Silver Book Fact

Fact image

Heart Failure Disease Management (DM) Program Reduces Hospitalizations and Overall Costs

PhRMA. The Value of Medicines: Facts and figures 2006; 2006. http://innovation.org/documents/Value%20of%20Medicine%20FINAL%200712061.pdf

Reference

Title
The Value of Medicines: Facts and figures 2006
Publication Date
2006
Authors
PhRMA
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Medicines in Development for Heart Disease and Stroke, 2008  
  • From 1979 to 2005, the number of cardiac catheterizations increased 342% to 1,322,000 annually.  
  • The projected economic value of eliminating deaths from stroke is $7.6 trillion.  
  • Cost-effectiveness of SAVR
    The cost-effectiveness ratio for surgical aortic valve replacement (SAVR), compared to no surgery, was estimated at $13,528 per quality-adjusted life year (QALY) (~$17,225 in 2017 dollars).  
  • Decrease in AFib hospitalization rates
    The use of practice guidelines in atrial fibrillation patients saw a decrease in rate of hospitalization from 74%to 38%.